Breaking the cycle of recurrent urinary tract infections in women: a network meta-analysis of superior preventive measures
Abstract
Recurrent urinary tract infections (rUTI) impose a substantial burden, particularly on vulnerable populations, such as women. The importance of effective prevention strategies is crucial in reducing the incidence of rUTI. While various preventive measures are available, there remains a gap in knowledge regarding their effectiveness and safety in clinical practice. This study aims to evaluate various interventions’ performance in reducing the risk of rUTI and safety compared to placebo in healthy women. This network meta-analysis (NMA) was conducted according to the Systematic Reviews and Meta-Analyses Preferred Reporting Items for Systematic Reviews and Meta-Analyses NMA Checklist. A systematic search was performed in Scopus, PubMed, CENTRAL, EBSCO, Hindawi, and ProQuest up to June 14th, 2024. Studies that met our eligibility criteria are qualitatively assessed using the Cochrane Risk of Bias Tool 2. Data analysis was conducted using Rstudio v.4.3.1 with the DerSimonian-Laird random-effects model. The p-value was calculated to rank treatments. There were 6325 samples obtained from 40 journals. Fosfomycin-trometamol is the best intervention in preventing rUTI in women [p=0.9965; relative risk (RR)=0.09; 95% confidence interval (CI) 0.05-0.17]. Cranberry extract (p=0.62; RR=0.38; 95% CI 0.24-0.60) and nitrofurantoin (p=0.617; RR=0.38; 95% CI 0.27-0.53) have the most evidence with acceptable RR. Combinations of lactobacillus, cranberry, and D-mannose resulted in the lowest…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.